The initial success of Ozempic initially made Novo Nordisk Europe’s most valuable company - David J. Phillip/AP The wealthy foundation behind Ozempic maker Novo Nordisk has seized control of the company in a boardroom coup after a row over the struggling group’s turnaround. On Monday, the pharmaceutical giant said chairman Helge Lund and six independent directors would resign and be replaced by a group hand-picked by its biggest shareholder, the Novo Nordisk Foundation. The drugmaker, which makes the an ...